Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
Vietnam
· Delayed Price · Currency is VND 17,700
+1,500 (9.26%)
At close: Apr 29, 2026
HNX:MKV Revenue
Cai Lay Veterinary Pharmaceutical JSC had revenue of 36.03B VND in the quarter ending March 31, 2026, with 7.82% growth. This brings the company's revenue in the last twelve months to 152.40B, up 31.03% year-over-year. In the year 2025, Cai Lay Veterinary Pharmaceutical JSC had annual revenue of 149.79B with 39.94% growth.
Revenue (ttm)
152.40B
Revenue Growth
+31.03%
P/S Ratio
0.58
Revenue / Employee
1.36B
Employees
112
Market Cap
88.50B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SPM Corporation | 217.45B |
| Lamdong Pharmaceutical JSC | 242.87B |
| Phong Phu Pharmaceutical JSC | 139.74B |
| American Vietnamese Biotech Incorporation | 154.07B |
| Vimedimex Medi-Pharma JSC | 812.98B |
| Ben Tre Pharmaceutical JSC | 860.31B |
| Mediplantex National Pharmaceutical JSC | 366.83B |
| Vidipha Central Pharmaceutical JSC | 971.25B |